Results 191 to 200 of about 223,105 (281)

Day‐30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation

open access: yesBritish Journal of Haematology, EarlyView.
Summary While plasma‐derived proteins have emerged as potential biomarkers for prognosis after haematopoietic stem cell transplantation (HSCT), there are insufficient data assessing if established proteins interleukin 1 receptor‐like 1 (IL1RL1), chemokine ligand 9 (CXCL9) and regenerating islet‐derived 3‐α (REG3α) retain their utility in the mismatched
Trent Wang   +8 more
wiley   +1 more source

Mast Cells in Acute COVID‐19 Patients

open access: yes
Allergy, EarlyView.
Ilan Zaffran   +8 more
wiley   +1 more source

Cardiac Markers in Apparently Non-COVID-19 Individuals and Post-COVID-19 Individuals with and without Metabolic Syndrome, Trujillo-Peru 2023

open access: yes
Jorge Luis Díaz-Ortega,1 Nelida Milly Otiniano,2 Irma Luz Yupari-Azabache,2 Juan M Alva Sevilla3 1Escuela Profesional de Nutrición, Universidad César Vallejo, Trujillo, Perú; 2Institutos y Centros de Investigación, Universidad César Vallejo, Trujillo ...
Yupari-Azabache IL   +3 more
core  

E-cigarettes are not associated with post-acute COVID-19 syndrome among US adults. [PDF]

open access: yesSci Rep
Rajai Firouzabadi S   +3 more
europepmc   +1 more source

Exercise intervention for post-acute COVID-19 syndrome - do FITT-VP principles apply? A case study. [PDF]

open access: yesS Afr J Sports Med, 2023
Torres G   +3 more
europepmc   +1 more source

Human brain matters: Navigating the neuropathology of COVID‐19

open access: yesBrain Pathology, EarlyView.
Severe COVID‐19 is associated with vascular dysregulation and chronic neuroinflammation, leading to axonal injury and neurodegeneration. In long COVID or PASC, persistent alterations in neuroimaging and biofluid biomarkers reflect ongoing neuronal damage and neuroinflammation, contributing to long‐term neurological symptoms including fatigue, cognitive
Juliana M. Nieuwland   +4 more
wiley   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown   +2 more
wiley   +1 more source

Spinal Neuromodulation for Respiratory Rehabilitation in Patients with Post-Acute COVID-19 Syndrome. [PDF]

open access: yesLife (Basel)
Ovechkin A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy